AU6174586A - Substituted toluidines, a process for their preparation pharmaceutical formulations containing them, and their use as inhibitors of gastric acid secretion - Google Patents

Substituted toluidines, a process for their preparation pharmaceutical formulations containing them, and their use as inhibitors of gastric acid secretion

Info

Publication number
AU6174586A
AU6174586A AU61745/86A AU6174586A AU6174586A AU 6174586 A AU6174586 A AU 6174586A AU 61745/86 A AU61745/86 A AU 61745/86A AU 6174586 A AU6174586 A AU 6174586A AU 6174586 A AU6174586 A AU 6174586A
Authority
AU
Australia
Prior art keywords
inhibitors
pharmaceutical formulations
formulations containing
gastric acid
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU61745/86A
Other versions
AU595231C (en
AU595231B2 (en
Inventor
Andreas W. Herling
Hans-Jochen Lang
Gerhard Rackur
Manfred Rosner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853530342 external-priority patent/DE3530342A1/en
Priority claimed from DE19863610609 external-priority patent/DE3610609A1/en
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU6174586A publication Critical patent/AU6174586A/en
Application granted granted Critical
Publication of AU595231B2 publication Critical patent/AU595231B2/en
Publication of AU595231C publication Critical patent/AU595231C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU61745/86A 1985-08-24 1986-08-22 Substituted toluidines, a process for their preparation pharmaceutical formulations containing them, and their use as inhibitors of gastric acid secretion Ceased AU595231C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19853530342 DE3530342A1 (en) 1985-08-24 1985-08-24 Substituted toluidines, processes for their preparation, pharmaceutical preparations containing them and their use as gastric acid secretion inhibitors
DE3530342 1985-08-24
DE19863610609 DE3610609A1 (en) 1986-03-29 1986-03-29 Substituted toluidines, processes for their preparation, pharmaceutical preparations containing them and their use as gastric secretion inhibitors
DE3610609 1986-03-29

Publications (3)

Publication Number Publication Date
AU6174586A true AU6174586A (en) 1987-02-26
AU595231B2 AU595231B2 (en) 1990-03-29
AU595231C AU595231C (en) 1991-08-15

Family

ID=

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597628B2 (en) * 1987-03-30 1990-06-07 Higuchi, Yoshinari Hydroquinoline compounds, compositions containing same and process for preparing same
AU599607B2 (en) * 1985-10-16 1990-07-26 Fisons Plc Heterocyclic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599607B2 (en) * 1985-10-16 1990-07-26 Fisons Plc Heterocyclic compounds
AU597628B2 (en) * 1987-03-30 1990-06-07 Higuchi, Yoshinari Hydroquinoline compounds, compositions containing same and process for preparing same

Also Published As

Publication number Publication date
DE3687675D1 (en) 1993-03-18
AU595231B2 (en) 1990-03-29
ES2001389A6 (en) 1988-05-16
PH24073A (en) 1990-03-05
EP0213474A3 (en) 1987-05-20
NO863389D0 (en) 1986-08-22
NO169169C (en) 1992-05-20
NZ217322A (en) 1990-02-26
DK401586A (en) 1987-02-25
AR243167A1 (en) 1993-07-30
PT83240B (en) 1989-03-30
EP0213474A2 (en) 1987-03-11
IE59587B1 (en) 1994-03-09
FI863382A (en) 1987-02-25
GR862180B (en) 1986-12-23
JPH0791276B2 (en) 1995-10-04
ATE85328T1 (en) 1993-02-15
NO863389L (en) 1987-02-25
NO169169B (en) 1992-02-10
KR870002087A (en) 1987-03-30
DK401586D0 (en) 1986-08-22
FI89910B (en) 1993-08-31
PT83240A (en) 1986-09-01
FI863382A0 (en) 1986-08-21
FI89910C (en) 1993-12-10
KR940005020B1 (en) 1994-06-09
IL79813A0 (en) 1986-11-30
EP0213474B1 (en) 1993-02-03
HUT44242A (en) 1988-02-29
JPS6251671A (en) 1987-03-06
HU199126B (en) 1990-01-29

Similar Documents

Publication Publication Date Title
AU590390B2 (en) Substituted thienoimidazole derivatives, a process for their preparation, pharmaceutical compositions containing them, and their use as inhibitors of gastric acid secretion
DE2960293D1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
AU5231186A (en) Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them
IL78942A0 (en) Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
PT84064A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
PT82121B (en) Process for the preparation of novel aromatic heterocyclic acid derivatives and of pharmaceutical compositions containing the same
IL79792A0 (en) Amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL79813A0 (en) Substituted toluidines,a process for their preparation,pharmaceutical formulations containing them,and their use as inhibitors of gastric acid secretion
PT83565A (en) Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same
IL87122A0 (en) Substituted thienoinidazole derivatives,process for the preparation thereof,pharmaceutical compositions containing them,and the use thereof as inhibitors of gastric acid secretion,as gastroprotectives and as medicaments for intestinal inflammations
IL87876A0 (en) Catechol carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0216127A3 (en) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones, process for their preparation, their use as medicines, pharmaceutical compositions and intermediates
AU8144887A (en) Substituted thienoimidazole-toluidine derivatives, a process for their preparation, pharmaceutical compositions containing them, and their use as inhibitors of gastric acid secretion
ZA864504B (en) Derivatives of 2-fluoroalkylbenzimidazole,process for their preparation and pharmaceutical compositions containing them
LTIP1682A (en) Novel 16,17-acetal-substituted derivatives of pregnan-21-oic acid, process for preparing thereof, pharmaceutical preparations containing them
AU595231C (en) Substituted toluidines, a process for their preparation pharmaceutical formulations containing them, and their use as inhibitors of gastric acid secretion
DE3661070D1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
ZA866369B (en) Substituted toluidines,a process for their preparation,pharmaceutical formulations containing them,and their use as inhibitors of gastric acid secretion
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
IL87428A0 (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors
AU2065188A (en) Substituted thienoimidazole derivatives, processes for their preparation, pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors
ZA888395B (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical preparations containing them and their use as inhibitors of gastric acid secretion
ZA871216B (en) Substituted thienoimidazole derivatives,a process for their preparation,pharmaceutical compositions containing them,and their use as inhibitors of gastric acid secretion
ZA885920B (en) Substituted thienoimidazole derivatives,processes for their preparation,pharmaceutical formulations containing them and their use as castric acid secretion inhibitors
AU5891686A (en) Process for the preparation of 2-halonicergoline derivatives and their acid addition salts and new 2-halonicergolines